Variant report
Variant | nsv159209 |
---|---|
Chromosome Location | chr1:169607718-169613389 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs554878641 | chr1:169607745-169607746 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs80270964 | chr1:169607749-169607750 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs145730963 | chr1:169607794-169607795 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs368644706 | chr1:169607850-169607851 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs564978226 | chr1:169607866-169607867 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs148897105 | chr1:169607896-169607897 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs187986035 | chr1:169607916-169607917 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs535986866 | chr1:169607938-169607939 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs559024188 | chr1:169607987-169607988 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs114933619 | chr1:169608024-169608025 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs547798550 | chr1:169608034-169608035 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs9659257 | chr1:169608068-169608069 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs375562685 | chr1:169608074-169608075 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs74646590 | chr1:169608078-169608079 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs570997185 | chr1:169608106-169608107 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs535231120 | chr1:169608150-169608151 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs191338885 | chr1:169608201-169608202 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs183875339 | chr1:169608206-169608207 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs535817298 | chr1:169608243-169608244 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs557428367 | chr1:169608265-169608266 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs188658965 | chr1:169608306-169608307 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs543390563 | chr1:169608321-169608322 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs558821892 | chr1:169608425-169608426 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs181488778 | chr1:169608430-169608431 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs143620872 | chr1:169608442-169608443 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs558988080 | chr1:169608449-169608450 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs75743141 | chr1:169608608-169608609 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs541402491 | chr1:169608609-169608610 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs371620557 | chr1:169608676-169608677 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs563184333 | chr1:169608680-169608681 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs531227734 | chr1:169608693-169608694 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs558173559 | chr1:169608755-169608756 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs578086053 | chr1:169608791-169608792 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs552555874 | chr1:169608798-169608799 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs77545736 | chr1:169608799-169608800 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs142190425 | chr1:169608874-169608875 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs1569476 | chr1:169608917-169608918 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundancedisease |
38 | rs568554389 | chr1:169608944-169608945 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs563359709 | chr1:169608960-169608961 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs535984720 | chr1:169608968-169608969 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs145821416 | chr1:169608985-169608986 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs569113903 | chr1:169609037-169609038 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs573382157 | chr1:169609192-169609193 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs539821614 | chr1:169609206-169609207 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs558541550 | chr1:169609221-169609222 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs577082025 | chr1:169609252-169609253 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs534492327 | chr1:169609291-169609292 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs369030602 | chr1:169609308-169609309 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs552777147 | chr1:169609313-169609314 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs187134246 | chr1:169609329-169609330 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Schizophrenia | 19415332 | CNVD |
Autism | 22495311 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Liposarcoma | 21253554 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Melanoma | 18172304 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Cancer | 21183584 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Rett syndrome | 21593744 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 17133270 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Cervical cancer | 21063398 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 20632083 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Medulloblastoma | 21292688 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 21264507 | CNVD |
Multiple myeloma | 21628407 | CNVD |
Cancer | 16751803 | CNVD |
Prostate cancer | 16705090 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Breast cancer | 17850661 | CNVD |
Breast cancer | 16461572 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Bladder cancer | 19088036 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Breast cancer | 21858162 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 16608533 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Chordoma | 18071362 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17001317 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21509527 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Trisomy 5 syndrome | 21098271 | CNVD |
Ependymoma | 18628472 | CNVD |
Leukemia | 18628472 | CNVD |
Breast cancer | 21611746 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Soft tissue tumor | 16732325 | CNVD |
Cancer | 17060936 | CNVD |
Lung cancer | 16740712 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Acute lymphoblastic leukemia | 19100363 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Williams-beuren syndrome | 16971481 | CNVD |
Developmental delay | 21147756 | CNVD |
Burkitt''s lymphoma | 20823134 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Lung cancer | 18438408 | CNVD |
Cancer | 20164920 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:169605200-169617000 | Weak transcription | Primary T helper memory cells from peripheral blood 1 | blood |
2 | chr1:169608600-169609000 | Enhancers | Primary T helper cells PMA-I stimulated | -- |
3 | chr1:169608600-169609200 | Enhancers | Dnd41 | blood |
4 | chr1:169608800-169609000 | Enhancers | Primary T helper cells fromperipheralblood | blood |
5 | chr1:169608800-169609200 | Enhancers | Primary T helper memory cells from peripheral blood 2 | blood |
6 | chr1:169609000-169616400 | Weak transcription | Primary T helper cells PMA-I stimulated | -- |
7 | chr1:169609000-169616800 | Weak transcription | Primary T helper cells fromperipheralblood | blood |
8 | chr1:169609200-169610600 | Weak transcription | Dnd41 | blood |
9 | chr1:169609800-169611800 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
10 | chr1:169610000-169611600 | Enhancers | Primary hematopoietic stem cells | blood |
11 | chr1:169610000-169612000 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
12 | chr1:169610600-169610800 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
13 | chr1:169610600-169611600 | Enhancers | Dnd41 | blood |
14 | chr1:169610600-169611800 | Enhancers | Primary B cells from peripheral blood | blood |
15 | chr1:169610800-169611600 | Enhancers | Primary T cells from cord blood | blood |
16 | chr1:169611000-169611400 | Enhancers | Primary B cells from cord blood | blood |
17 | chr1:169611000-169611400 | Enhancers | Primary Natural Killer cells fromperipheralblood | blood |
18 | chr1:169611000-169611600 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
19 | chr1:169611200-169611600 | Enhancers | Fetal Thymus | thymus |
20 | chr1:169611600-169616600 | Weak transcription | Primary T cells from cord blood | blood |
21 | chr1:169611600-169616800 | Weak transcription | Dnd41 | blood |
22 | chr1:169611800-169618000 | Weak transcription | Primary B cells from peripheral blood | blood |